July 17, 2013—The Health Resources and Services Administration (HRSA) has released 16 more summaries of the findings from its audits of 340B covered entities in 2012. … [Read more...]
340B Coalition Honors Senator Harkin
Veteran Iowa lawmaker receives group's lifetime achievement awardJuly 16, 2013— Senator Tom Harkin (D-Iowa) received the 340B Coalition's Lifetime Achievement Award yesterday during a ceremony opening the group's 17th Annual Conference, held in Washington, D.C. The coalition represents safety-net health care providers that participate in the 340B drug discount program. … [Read more...]
Senate Appropriators Say 340B Is Not Just an “Individual Discount”
Committee's report language supports providers' position in debate over program's purposeJuly 15, 2013—The full Senate Appropriations Committee has strongly reaffirmed that the 340B program is "more than simply an individual discount program" in report language accompanying its fiscal 2014 spending bill for labor, health, and education programs. … [Read more...]
Senator Grassley, PhRMA Respond to 340B Hospitals’ Report
Lawmaker says study isn't "objective" while drugmakers raise doubts about program in its "current form"July 12, 2013—The Senate Republican who has been examining hospitals' participation in the 340B program and the trade association for brand-name drug manufacturers have responded to a major new report on the 340B drug discount program. … [Read more...]
Coalition of Hospital Groups Underscores 340B’s Importance
Report and website describe program's value and respond to its criticsJuly 9, 2013—Three associations that represent a broad group of hospitals in the 340B drug discount program joined together today to highlight how the program "benefits vulnerable patients, including those with little or no ability to pay." … [Read more...]
Setting the Record Straight on 340B: A Response to Critics
A new, comprehensive report released today corrects misinformation about a federal drug discount program and underscores how the program benefits vulnerable patients, including those with little or no ability to pay. Click here for the complete 27-page report. The report finds that the 340B drug pricing program continues to meet Congress’ intent of “enabling safety net … [Read more...]
What Is 340B?
Congress created the 340B Drug Discount Program in 1992 to reduce outpatient prescription drug costs for safety net health care providers, enabling them to stretch scarce resources as far as possible, reaching more eligible patients and providing more comprehensive services. The program was enacted with strong bipartisan support from Congress and signed into law by President … [Read more...]